Sherri Cervantez in San Antonio, Texas

Additional Medical Specialties Include:
HOSPICE/PALLIATIVE CARE

Medical School: Sorry, her university is not listed
Graduation Year: 2010
The Primary Medical Specialty for Sherri Cervantez is listed as: Hematology/oncology
Approximate Years of Experience: 14
PAC (PECOS ID)#: 8820239874
NPI #: 1760708291
NPI Created On: 04/08/2010
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207RH0002X
License Number:
R3044
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Bladder instillation of cancer preventive, inhibiting, or suppressive agent
2. Hydration infusion into a vein
3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
8. Infusion of chemotherapy into a vein up to 1 hour
9. Infusion of chemotherapy into a vein
10. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
11. Irrigation of implanted venous access drug delivery device
12. New patient office or other outpatient visit, typically 45 minutes
13. New patient office or other outpatient visit, typically 60 minutes
14. Established patient office or other outpatient visit, typically 15 minutes
15. Established patient office or other outpatient, visit typically 25 minutes
16. Established patient office or other outpatient, visit typically 40 minutes
17. Physician telephone patient service, 11-20 minutes of medical discussion
18. Physician telephone patient service, 21-30 minutes of medical discussion
19. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
20. Injection, denosumab, 1 mg